PROCEPT BioRobotics Corporation (NASDAQ:PRCT) is one of the Fast-Growing Small Cap Stocks to Buy According to Analysts. On ...
The average one-year price target for PROCEPT BioRobotics (NasdaqGM:PRCT) has been revised to $55.27 / share. This is a ...
SAN JOSE, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing ...
Get the latest PROCEPT BioRobotics Q3 2025 earnings call insights, revenue growth, strategy updates, and future outlook.
MMI won FDA approval to study robotic surgery for Alzheimer’s disease. Elsewhere, SS Innovations’ CEO performed remote bypass ...
Wells Fargo lowered the firm’s price target on Procept BioRobotics (PRCT) to $51 from $58 and keeps an Overweight rating on the shares. The firm ...
SAN JOSE, Calif., July 24, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics (“the Company”), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology ...
InvestingPro Insights The recent stock transactions by PROCEPT BioRobotics Corp's CEO Reza Zadno align with the company's strong market performance. According to InvestingPro data, PROCEPT has shown ...
We recently compiled a list of the 20 Hidden Gem AI Stocks. In this article, we are going to take a look at where PROCEPT BioRobotics Corporation (NASDAQ:PRCT) stands against the other hidden gem AI ...
In other recent news, Procept BioRobotics Corp reported its fourth-quarter 2024 earnings, revealing a revenue of $68.24 million, surpassing the forecast of $66.83 million. Despite this revenue beat, ...
On Thursday, Spruce Point Capital released a detailed report on PROCEPT BioRobotics (NASDAQ:PRCT), raising concerns about the claims surrounding its market potential and growth prospects, suggesting ...
Larry L. Wood to join PROCEPT BioRobotics effective September 2, 2025 Company confirms strong underlying business trends and pre-announces 2Q25 revenue of approximately $79.2 million, representing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback